ADJUVANT XELOX CHEMOTHERAPY OUTCOMES IN HIGH-RISK STAGE II AND STAGE III COLON CANCER: EVIDENCE FROM THAI BINH GENERAL HOSPITAL. Vietnam Journal of Community Medicine, v. 67, n. 10, 31 Oct.2026.